Digital Genome Is A Vital Part Of Modern Healthcare, And Is Widely Used In Genetic, Agriculture And Biopharmaceutical Industries
Digital Genome |
Digital Genome technology
can provide unprecedented insight into complex genetic systems. It is used for
a variety of applications, including medical diagnosis, forensics, research
& development, agriculture, and reproductive & genetics. End-users
include biopharmaceutical companies, medical diagnostic centers, and academic
& research institutes. Digital Genomes are also being used for early
disease detection.
The
technology allows researchers to edit and manipulate entire genetic elements,
including known genes and genomic regions that are not functionally annotated.
It also enables phenotyping of variant libraries and provides Genome-scale
access to genetic information. Digital
Genome technologies are helping scientists address genomic problems
such as identifying splice sites and annotating genomic sequence elements. For
example, Congenica has developed a clinical genomics analysis platform called
Sapientia, which prioritizes variants from whole-exome sequencing.
These
tools help researchers better understand how genes interact with one another in
complex systems. For example, they can map disease-associated genes to
protein-protein interaction networks. These genes tend to cluster into modules.
This allows researchers to prioritize individual genes within a module. This
information can be used to develop digital twins of individual patients.
Researchers
are developing more efficient enzymes to accelerate the data writing process.
They are also working on shrinking the size of the growing cell populations and
increasing the number of populations that can be analyzed at once. Personalized
medicine is another trend that will continue to grow and these medicines are
based on patient's genetic information as they provide targeted treatment. One
of the fastest-growing digital Genome products is sequencing chips.
Gencove
has launched its InfiniSEEK platform to aid in the analysis of whole Genomes. Inscripta
has launched the Onyx(tm) Digital Genome Engineering platform, the world's
first benchtop instrument to support Genome-scale engineering. The platform
includes software, consumables, and assays. It enables researchers to generate
gene-based products and support Genome discovery and bio-industrial
development.
In
January, 2020, Germany signed the declaration and joined the 1+Million sequenced
Genomes initiative in the European Union for 2022. This declaration was
launched in 2018, which is a collaborated mechanism aiming to enhance
prevention of diseases, improve personalized treatments and also provide
sufficient scale for new research. Germany has become the 21st member to join
this initiative.
Comments
Post a Comment